Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
US Stock MarketDetailed Quotes
BNS Bank of Nova Scotia
- 53.700
- +0.310+0.58%
Close Jan 6 16:00 ET
- 53.700
- 0.0000.00%
Post 20:01 ET
73.08BMarket Cap13.11P/E (TTM)
54.250High53.610Low7.68MVolume54.150Open53.390Pre Close413.51MTurnover0.57%Turnover Ratio13.11P/E (Static)1.36BShares56.22952wk High1.42P/B72.25BFloat Cap42.40352wk Low3.04Dividend TTM1.35BShs Float61.459Historical High5.67%Div YieldTTM1.20%Amplitude2.903Historical Low53.853Avg Price1Lot Size
Bank of Nova Scotia Key Stats
Quarterly+Annual
YOY
| (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -50.66%15.65B | 51.54%7.19B | -69.51%7.11B | 92.52%-950M | -85.95%2.3B | 87.24%31.72B | 300.51%4.75B | 335.13%23.33B | -236.97%-12.7B | -18.05%16.35B |
| Net income from continuing operations | 5.93%7.89B | 24.74%1.69B | -12.77%1.91B | -2.52%2.09B | 25.09%2.2B | -26.77%7.45B | -35.31%1.35B | -15.50%2.19B | -21.88%2.15B | -35.84%1.76B |
| Operating gains losses | 83.05%-110M | 83.07%-65M | 194.12%80M | 36.67%-76M | 18.33%-49M | -495.41%-649M | -439.82%-384M | -93.18%-85M | -41.18%-120M | 35.48%-60M |
| Depreciation and amortization | -3.30%1.76B | -15.08%501M | 3.88%428M | -0.49%410M | 3.69%421M | 18.88%1.82B | 49.75%590M | 8.14%412M | 8.14%412M | 8.27%406M |
| Deferred tax | -8.51%2.03B | 278.52%511M | -9.26%451M | 10.95%537M | -51.76%533M | -19.47%2.22B | -71.58%135M | -17.44%497M | -40.76%484M | 27.89%1.11B |
| Other non cashItems | -5.42%-19.25B | -5.51%-4.92B | -6.32%-4.86B | -5.25%-4.69B | -4.60%-4.77B | -0.81%-18.26B | -0.95%-4.67B | 2.20%-4.57B | 0.29%-4.46B | -5.04%-4.56B |
| Change in working capital | -87.79%1.89B | 204.83%4.35B | -80.97%3.64B | 73.21%-4.55B | -113.01%-1.55B | 405.12%15.48B | 123.96%1.43B | 237.17%19.1B | -384.69%-16.98B | -29.79%11.93B |
| -Change in loans | 704.98%11.15B | -94.32%1.1B | -149.78%-3.37B | 249.75%12B | 108.52%1.43B | 101.08%1.39B | 169.37%19.34B | 117.43%6.77B | 74.16%-8.01B | 44.37%-16.72B |
| -Change in other working capital | -165.71%-9.26B | 118.17%3.26B | -43.21%7B | -84.45%-16.54B | -110.39%-2.98B | -89.23%14.09B | -181.70%-17.92B | -50.46%12.33B | -124.26%-8.97B | -39.10%28.64B |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -50.66%15.65B | 51.54%7.19B | -69.51%7.11B | 92.52%-950M | -85.95%2.3B | 87.24%31.72B | 300.51%4.75B | 335.13%23.33B | -236.97%-12.7B | -18.05%16.35B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 75.20%-7.45B | 1.60%-6.22B | 73.28%-5.46B | -65.65%5.42B | 93.74%-1.19B | -166.01%-30.04B | -225.28%-6.32B | -362.12%-20.42B | 298.18%15.77B | -17.94%-19.07B |
| Proceeds payment in interest bearing deposits in bank | 208.58%25.56B | -720.75%-5.26B | 98.39%-384M | -48.82%10.16B | 211.16%21.04B | -191.29%-23.54B | -110.75%-641M | -243.40%-23.83B | 47.85%19.86B | -85.02%-18.93B |
| Net investment purchase and sale | -420.96%-31.49B | 91.33%-524M | -230.37%-4.7B | -15.30%-4.35B | -12,769.36%-21.92B | 82.53%-6.04B | -5,659.05%-6.05B | 142.88%3.6B | 81.54%-3.77B | 103.05%173M |
| Net PPE purchase and sale | -10.63%-489M | 20.92%-121M | 38.25%-134M | -450.00%-88M | -160.71%-146M | 22.59%-442M | 13.56%-153M | -10.71%-217M | 89.54%-16M | -24.44%-56M |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | 263.02%895M | ---- | ---- | ---- | ---- |
| Net other investing changes | -13.17%-1.03B | 16.35%-312M | -1,030.77%-242M | -2.65%-310M | 36.26%-167M | 32.52%-911M | 53.43%-373M | 115.38%26M | -97.39%-302M | -15.42%-262M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 75.20%-7.45B | 1.60%-6.22B | 73.28%-5.46B | -65.65%5.42B | 93.74%-1.19B | -166.01%-30.04B | -225.28%-6.32B | -362.12%-20.42B | 298.18%15.77B | -17.94%-19.07B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -219.52%-8.84B | 20.73%-784M | -471.48%-2.16B | -85.29%-4.03B | -911.96%-1.86B | 39.59%-2.77B | 25.64%-989M | -44.68%582M | -75.69%-2.18B | 93.99%-184M |
| Net issuance payments of debt | -344.54%-2.55B | -65.12%-71M | -162.26%-574M | 10.34%-78M | -826.19%-1.83B | -40.61%1.04B | 53.76%-43M | 1,184.71%922M | -104.30%-87M | 383.15%252M |
| Net commonstock issuance | 38.73%1.95B | 4.77%505M | 3.43%483M | 9.11%467M | 1,860.00%490M | 151.24%1.4B | 491.87%482M | 216.17%467M | 134.83%428M | 102.55%25M |
| Net preferred stock issuance | --704M | --0 | --0 | --0 | --704M | --0 | --0 | --0 | --0 | --0 |
| Cash dividends paid | -4.57%-5.67B | -3.32%-1.43B | -3.56%-1.42B | -6.54%-1.42B | -4.97%-1.4B | -5.94%-5.42B | -4.05%-1.39B | -8.70%-1.38B | -4.89%-1.33B | -6.24%-1.33B |
| Net other financing activities | -1,654.29%-3.26B | 624.39%215M | -213.91%-647M | -153.25%-3B | -80.53%169M | 141.50%210M | 94.90%-41M | -56.44%568M | -54.90%-1.19B | 460.17%868M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -219.52%-8.84B | 20.73%-784M | -471.48%-2.16B | -85.29%-4.03B | -911.96%-1.86B | 39.59%-2.77B | 25.64%-989M | -44.68%582M | -75.69%-2.18B | 93.99%-184M |
| Net cash flow | ||||||||||
| Beginning cash position | -8.06%10.17B | -26.77%9.25B | 5.13%9.77B | 10.96%9.21B | -8.06%10.17B | 14.15%11.07B | 34.23%12.64B | -12.69%9.29B | -21.41%8.3B | 14.15%11.07B |
| Current changes in cash | 41.22%-636M | 107.42%190M | -114.47%-505M | -50.95%437M | 73.87%-758M | -201.03%-1.08B | -290.20%-2.56B | 423.45%3.49B | 1,027.85%891M | -500.69%-2.9B |
| Effect of exchange rate changes | -168.95%-131M | -137.00%-37M | 92.52%-11M | 21.00%121M | -248.91%-204M | -36.88%190M | -67.21%100M | 2.65%-147M | 9,900.00%100M | -6.16%137M |
| End cash position | -7.54%9.41B | -7.54%9.41B | -26.77%9.25B | 5.13%9.77B | 10.96%9.21B | -8.06%10.17B | -8.06%10.17B | 34.23%12.64B | -12.69%9.29B | -21.41%8.3B |
| Free cash flow | -51.53%15.16B | 53.95%7.07B | -69.80%6.98B | 91.84%-1.04B | -86.80%2.15B | 91.07%31.28B | 280.54%4.59B | 328.43%23.11B | -239.45%-12.72B | -18.15%16.3B |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |